India to Thailand: Gemcitabine Export Trade Route
India has recorded 79 verified shipments of Gemcitabine exported to Thailand, representing a combined trade value of $2.3M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $28.8K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 75% of total export value with 51 shipments worth $1.7M USD. On the buying side, FRESENIUS KABI (THAILAND) LTD., is the largest importer in Thailand with $495.5K USD in purchases. The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Thailand Gemcitabine corridor is one of India's established pharmaceutical export routes, with 79 shipments documented worth a combined $2.3M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's gemcitabine manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $28.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with gemcitabine's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #11 among India's top gemcitabine export destinations globally.
On the import side, key buyers of Indian gemcitabine in Thailand include FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LIMITED, FRESENIUS KABI (THAILAND) LTD and 11 others. FRESENIUS KABI (THAILAND) LTD., is the single largest importer with 17 shipments valued at $495.5K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#11
- Annual growth+32.5%
- Demand growth+27.1%
- Regulatory ease77/100
Top 10 Indian Gemcitabine Exporters to Thailand
Showing top 10 of 7 Indian suppliers exporting Gemcitabine to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $33.5K per shipment | 51 | $1.7M | 75.0% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $37.7K per shipment | 15 | $565.8K | 24.8% |
| 3 | GLS PHARMA LIMITED Avg $1.9K per shipment | 1 | $1.9K | 0.1% |
| 4 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $612 per shipment | 3 | $1.8K | 0.1% |
| 5 | PROSPERA LIFE SCIENCES PRIVATE LIMITED Avg $383 per shipment | 2 | $766 | 0.0% |
| 6 | MEDYRA PHARMACEUTICAL Avg $185 per shipment | 2 | $370 | 0.0% |
| 7 | NISHCHEM INTERNATIONAL PRIVATE LIMITED Avg $0 per shipment | 5 | $0 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting gemcitabine to Thailand, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED, MBA PHARMACEUTICALS PRIVATE LIMITED, PROSPERA LIFE SCIENCES PRIVATE LIMITED , MEDYRA PHARMACEUTICAL, NISHCHEM INTERNATIONAL PRIVATE LIMITED. FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 51 shipments worth $1.7M USD, giving it a 75% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Gemcitabine Importers in Thailand
Showing top 10 of 14 known buyers in Thailand receiving Gemcitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gemcitabine in Thailand include FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LIMITED, FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD , among 14 total buyers. The largest importer is FRESENIUS KABI (THAILAND) LTD.,, accounting for $495.5K USD across 17 shipments — representing 22% of all gemcitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI (THAILAND) LTD., | 17 | $495.5K | 21.7% |
| 2 | FRESENIUS KABI THAILAND LIMITED | 12 | $408.4K | 17.9% |
| 3 | FRESENIUS KABI (THAILAND) LTD | 8 | $370.1K | 16.2% |
| 4 | FRESENIUS KABI THAILAND LTD | 9 | $295.8K | 13.0% |
| 5 | FRESENIUS KABI (THAILAND) LTD | 5 | $209.9K | 9.2% |
| 6 | FRESENIUS KABI (THAILAND) LTD., | 4 | $209.3K | 9.2% |
| 7 | FRESENIUS KABI(THAILAND)LTD | 6 | $146.7K | 6.4% |
| 8 | FRESENIUS KABI (THAILAND) LIMITED | 5 | $138.0K | 6.1% |
| 9 | MML CO.LTD. | 1 | $1.9K | 0.1% |
| 10 | TO THE ORDER OF THE MANAGER | 1 | $924 | 0.0% |
Showing top 10 of 14 Gemcitabine importers in Thailand on this route.
Top 10 Gemcitabine Formulations Imported by Thailand
Showing top 10 of 67 product formulations shipped on the India to Thailand Gemcitabine route, ranked by trade value
Thailand imports a wide range of gemcitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GEMITA ( GEMCITABINE ) USP INJ. 1.4GM/VI — accounts for $170.7K USD across 3 shipments. There are 67 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GEMITA ( GEMCITABINE ) USP INJ. 1.4GM/VI | 3 | $170.7K | 7.5% |
| 2 | GEMITA GEMCITABINE USP INJ. 1.4GM/VI | 2 | $116.6K | 5.1% |
| 3 | GEMITA(GEMCITABINE)USP INJ.1GM/VIAL BNO.87240016AA,87240037AA & 87240058AA MFD.01/24 EXD. 12/25 & MFD.02/24 EXD. 01/26 | 1 | $105.3K | 4.6% |
| 4 | GEMITA ( GEMCITABINE ) USP INJ. 1GM/VIAL | 2 | $101.3K | 4.4% |
| 5 | GEMITA GEMCITABINEUSP INJ.1GM/VIAL BNO | 1 | $93.7K | 4.1% |
| 6 | GEMITA(GEMCITABINE USP INJ.1GM/VIAL, BT# | 1 | $83.7K | 3.7% |
| 7 | GEMITA GEMCITABINE USP INJ. 1.4GM/VIAL | 2 | $74.9K | 3.3% |
| 8 | GEMITA ( GEMCITABINE ) USP INJ. 1GM/VIALBATCH NO. 87250013AB, MFG. DT. 01/2025,EXP. DT. 12/2026 (8232 VIALS) | 1 | $74.2K | 3.3% |
| 9 | GEMITA (GEMCITABINE) USP INJ.1.4GM VIAL | 1 | $71.4K | 3.1% |
| 10 | GEMITA (GEMCITABINE) USP INJ. 1.4GM/VIALVIAL BNO. 87240187BA MFG. DT. 05/2024EXP. DT. 04/2026 | 1 | $67.3K | 3.0% |
Showing top 10 of 67 Gemcitabine formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 35 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's gemcitabine exports to Thailand are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 51 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $28.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gemita gemcitabine usp inj. 1.4gm/vi and gemita(gemcitabine)usp inj.1gm/vial bno.87240016aa,87240037aa & 87240058aa mfd.01/24 exd. 12/25 & mfd.02/24 exd. 01/26, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI (THAILAND) LTD., is the largest importer with 17 shipments worth $495.5K USD — representing 22% of all gemcitabine imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.3M
- Avg. Shipment
- $28.8K
- Suppliers
- 7
- Buyers
- 14
- Transit (Sea)
- ~28 days
- Annual Growth
- +32.5%
Related Analysis
Other Gemcitabine Routes
Unlock the Full India to Thailand Gemcitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 79 shipments on this route.
Frequently Asked Questions — India to Thailand Gemcitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gemcitabine to Thailand?
The leading Indian exporters of Gemcitabine to Thailand are FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED. FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 75% of total trade value on this route.
Q What is the total value of Gemcitabine exports from India to Thailand?
India exports Gemcitabine to Thailand worth approximately $2.3M USD across 79 recorded shipments. The average value per shipment is $28.8K USD.
Q Which ports does India use to ship Gemcitabine to Thailand?
The most active port of origin is DELHI AIR with 35 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Thailand for Gemcitabine?
The average transit time for Gemcitabine shipments from India to Thailand is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Thailand Gemcitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.5% with demand growth tracking at 27.1%. The route is ranked #11 among India's top Gemcitabine export destinations globally.
Q How many suppliers are active on the India to Thailand Gemcitabine route?
There are currently 7 active Indian suppliers exporting Gemcitabine to Thailand. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 75% of total shipment value.
Q Who are the main importers of Gemcitabine from India in Thailand?
The leading importers of Indian Gemcitabine in Thailand include FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LIMITED, FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD . FRESENIUS KABI (THAILAND) LTD., is the largest buyer with 17 shipments worth $495.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Gemcitabine.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 14 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 79 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
79 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists